Roche at the 2018 ASH's 60th Annual Meeting
Agenda:
Welcome
Roche Hematology Strategy and Key data in CLL and AML
Key Data in NHL Nancy Valente, M.D., Vice President, Global Head of Hematology Development
Key Data in Hemophilia A Gallia Levy, M.D., Group Medical Director, Hemlibra Global Development Leader
Karl Mahler, Head of Investor Relations, Roche
Sandra Horning, M.D., Chief Medical Officer and Head of Global Product Development
Nancy Valente, M.D., Vice President, Global Head of Hematology Development
Gallia Levy, M.D., Group Medical Director, Hemlibra Global Development Leader

Please register to access the replay*

*Privacy notice

Roche has hosted a live audio webcast and conference call on Tuesday, 4 December 2018.

Investors
Past IR Events
View more Events

Downloads

Related links